NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 936 filers reported holding NOVARTIS A G in Q1 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $238,000 | -12.8% | 2,941 | -9.7% | 0.01% | -11.1% |
Q4 2017 | $273,000 | -9.3% | 3,256 | -7.1% | 0.01% | -18.2% |
Q3 2017 | $301,000 | +2.7% | 3,506 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $293,000 | +12.7% | 3,506 | 0.0% | 0.01% | +10.0% |
Q1 2017 | $260,000 | +1.6% | 3,506 | -0.3% | 0.01% | 0.0% |
Q4 2016 | $256,000 | -15.5% | 3,516 | -8.5% | 0.01% | -9.1% |
Q3 2016 | $303,000 | -4.4% | 3,841 | 0.0% | 0.01% | -8.3% |
Q2 2016 | $317,000 | +18.7% | 3,841 | +4.3% | 0.01% | +33.3% |
Q1 2016 | $267,000 | -16.8% | 3,681 | -1.5% | 0.01% | -10.0% |
Q4 2015 | $321,000 | +14.6% | 3,736 | +22.7% | 0.01% | +25.0% |
Q3 2015 | $280,000 | +1.8% | 3,046 | +8.9% | 0.01% | +14.3% |
Q2 2015 | $275,000 | -0.4% | 2,796 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $276,000 | +16.9% | 2,796 | +9.8% | 0.01% | +16.7% |
Q4 2014 | $236,000 | -1.7% | 2,546 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $240,000 | +4.3% | 2,546 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $230,000 | – | 2,546 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |